Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Faulkner Eric — CNS Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Faulkner Eric

Faulkner Eric

Chief Technology Officer at CNS Pharmaceuticals, Inc. · on record since Mar 4, 2026

Insider trading activity of Faulkner Eric

Transactions on record: 1; since Mar 4, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 4, 2026

Figures computed from official regulatory filings — methodology.

Companies where Faulkner Eric has traded

CNS Pharmaceuticals, Inc.1 tx · Mar 4, 2026

Track record of Faulkner Eric

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Faulkner Eric

Co-insiders of Faulkner Eric

Andraczke AndrzejCNS Pharmaceuticals, Inc.
Charles Faith L.CNS Pharmaceuticals, Inc.
Climaco John MCNS Pharmaceuticals, Inc.
Cockroft Bettina M.CNS Pharmaceuticals, Inc.
Cortice Biosciences, Inc.CNS Pharmaceuticals, Inc.
Downs ChristopherCNS Pharmaceuticals, Inc.
Evans Carl AnthonyCNS Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Gumulka JerzyCNS Pharmaceuticals, Inc.

Keyes Jeffry R.CNS Pharmaceuticals, Inc.

Levin RamiCNS Pharmaceuticals, Inc.

Mahery AmyCNS Pharmaceuticals, Inc.

O'Loughlin SteveCNS Pharmaceuticals, Inc.

Priebe WaldemarCNS Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
CNS Pharmaceuticals, Inc.	Mar 4, 2026	AwardD	9,500	—	—	SEC